Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.

Martin Filipits; Margaretha Rudas; Harald Heinzl; Raimund Jakesz; Ernst Kubista; Sigurd Lax; Walter Schippinger; Otto Dietze; Richard Greil; Wolfgang Stiglbauer; Werner Kwasny; Alexander Nader; Michael Stierer; Michael F X Gnant

doi:10.1158/1078-0432.CCR-09-0728

Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.

Martin Filipits, Margaretha Rudas, Harald Heinzl, Raimund Jakesz, Ernst Kubista, Sigurd Lax, Walter Schippinger, Otto Dietze (Co-author), Richard Greil (Co-author), Wolfgang Stiglbauer, Werner Kwasny, Alexander Nader, Michael Stierer, Michael F X Gnant

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

26 Citations (Web of Science)

Original language	English
Pages (from-to)	5888-5894
Journal	CLINICAL CANCER RESEARCH
Volume	15
Issue number	18
DOIs	https://doi.org/10.1158/1078-0432.CCR-09-0728
Publication status	Published - 2009

Keywords

KINASE INHIBITOR P27(KIP1)
CELL-CYCLE PROGRESSION
REGRESSION-MODELS
PROGNOSTIC IMPACT
RANDOMIZED-TRIAL
DUCTAL CARCINOMA
DOWN-REGULATION
CHEMOTHERAPY
SURVIVAL
RESISTANCE

Access to Document

10.1158/1078-0432.CCR-09-0728

Cite this

Filipits, M., Rudas, M., Heinzl, H., Jakesz, R., Kubista, E., Lax, S., Schippinger, W., Dietze, O., Greil, R., Stiglbauer, W., Kwasny, W., Nader, A., Stierer, M., & Gnant, M. F. X. (2009). Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy. CLINICAL CANCER RESEARCH , 15(18), 5888-5894. https://doi.org/10.1158/1078-0432.CCR-09-0728

Filipits, Martin ; Rudas, Margaretha ; Heinzl, Harald et al. / Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy. In: CLINICAL CANCER RESEARCH 2009 ; Vol. 15, No. 18. pp. 5888-5894.

@article{25fd251ddea940238ba8bd6345f0900c,

title = "Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.",

keywords = "KINASE INHIBITOR P27(KIP1), CELL-CYCLE PROGRESSION, REGRESSION-MODELS, PROGNOSTIC IMPACT, RANDOMIZED-TRIAL, DUCTAL CARCINOMA, DOWN-REGULATION, CHEMOTHERAPY, SURVIVAL, RESISTANCE",

author = "Martin Filipits and Margaretha Rudas and Harald Heinzl and Raimund Jakesz and Ernst Kubista and Sigurd Lax and Walter Schippinger and Otto Dietze and Richard Greil and Wolfgang Stiglbauer and Werner Kwasny and Alexander Nader and Michael Stierer and Gnant, {Michael F X}",

note = "Internal Medicine III, General Hospital Salzburg, Paracelsus Private Medical University, Salzburg, Austria",

year = "2009",

doi = "10.1158/1078-0432.CCR-09-0728",

language = "English",

volume = "15",

pages = "5888--5894",

journal = "CLINICAL CANCER RESEARCH ",

issn = "1078-0432",

publisher = "Amer Assoc Cancer Research",

number = "18",

}

Filipits, M, Rudas, M, Heinzl, H, Jakesz, R, Kubista, E, Lax, S, Schippinger, W, Dietze, O, Greil, R, Stiglbauer, W, Kwasny, W, Nader, A, Stierer, M & Gnant, MFX 2009, 'Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.', CLINICAL CANCER RESEARCH , vol. 15, no. 18, pp. 5888-5894. https://doi.org/10.1158/1078-0432.CCR-09-0728

Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy. / Filipits, Martin; Rudas, Margaretha; Heinzl, Harald et al.
In: CLINICAL CANCER RESEARCH , Vol. 15, No. 18, 2009, p. 5888-5894.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.

AU - Filipits, Martin

AU - Rudas, Margaretha

AU - Heinzl, Harald

AU - Jakesz, Raimund

AU - Kubista, Ernst

AU - Lax, Sigurd

AU - Schippinger, Walter

AU - Dietze, Otto

AU - Greil, Richard

AU - Stiglbauer, Wolfgang

AU - Kwasny, Werner

AU - Nader, Alexander

AU - Stierer, Michael

AU - Gnant, Michael F X

N1 - Internal Medicine III, General Hospital Salzburg, Paracelsus Private Medical University, Salzburg, Austria

PY - 2009

Y1 - 2009

KW - KINASE INHIBITOR P27(KIP1)

KW - CELL-CYCLE PROGRESSION

KW - REGRESSION-MODELS

KW - PROGNOSTIC IMPACT

KW - RANDOMIZED-TRIAL

KW - DUCTAL CARCINOMA

KW - DOWN-REGULATION

KW - CHEMOTHERAPY

KW - SURVIVAL

KW - RESISTANCE

U2 - 10.1158/1078-0432.CCR-09-0728

DO - 10.1158/1078-0432.CCR-09-0728

M3 - Original Article

C2 - 19723645

SN - 1078-0432

VL - 15

SP - 5888

EP - 5894

JO - CLINICAL CANCER RESEARCH

JF - CLINICAL CANCER RESEARCH

IS - 18

ER -

Filipits M, Rudas M, Heinzl H, Jakesz R, Kubista E, Lax S et al. Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy. CLINICAL CANCER RESEARCH . 2009;15(18):5888-5894. doi: 10.1158/1078-0432.CCR-09-0728